朝聚眼科医疗控股有限公司（股份代号02219）于2026年9月29日发布翌日披露报表，宣布在香港联合交易所场内回购普通股。本次回购涉及7万股，占该公司已发行股本约0.01%。
根据公告，本次回购价格区间介乎每股港币2.40元至2.45元，合计支付约港币16.89万。回购完成后，公司已发行股本仍为701,460,000股，库藏股数量维持为零。公告还显示，公司于2026年5月12日获得购回授权，授权总数为70,518,050股。截至目前，公司已在包括香港联交所等交易场所合计回购6,207,000股。
公告同时载明，公司已遵守香港联交所证券上市规则及相关法律法规。上述公告由执行董事兼联席公司秘书张光弟签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.